Pierre Vassilakos
Overview
Explore the profile of Pierre Vassilakos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1038
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Debeaudrap P, Kabore F, Setha L, Tegbe J, Doukoure B, Sotheara M, et al.
Int J Cancer
. 2024 Sep;
156(3):598-607.
PMID: 39319557
The WHO recommends the use of human papillomavirus (HPV) testing for primary cervical cancer (CC) screening because of its high sensitivity. However, triage is desirable to correctly identify HPV+ women...
2.
Wisniak A, Yakam V, Bolo S, Moukam A, Sormani J, Vassilakos P, et al.
BJOG
. 2024 Sep;
132(2):167-177.
PMID: 39279637
Objective: To assess the impact of thermal ablation (TA) for the treatment of cervical dysplasia on fertility and pregnancy outcomes among women screened for cervical cancer in Cameroon. Design: Retrospective...
3.
de Weck E, Vassilakos P, Wisniak A, Murtas M, Petignat P, Enow Orock G
Int J Gynecol Cancer
. 2024 Sep;
PMID: 39242101
No abstract available.
4.
Lalande E, Clarke H, Undurraga M, Nguyen V, Jaksic C, Goffin F, et al.
BMC Womens Health
. 2024 Mar;
24(1):189.
PMID: 38515088
Objective: To determine whether knowledge of cytology affects the colposcopist's diagnostic accuracy in the identification of cervical intraepithelial neoplasia grade 2 and worse (≥ CIN2). Method: In this cross-over study,...
5.
Bolo S, Kenfack B, Wisniak A, Tankeu G, Yakam V, Moukam A, et al.
BMC Womens Health
. 2024 Jan;
24(1):76.
PMID: 38281960
Background: Screening participation at recommended intervals is a crucial component of cervical cancer prevention effectiveness. However, little is known regarding the rate of re-screening in a Sub-Saharan context. This study...
6.
Stegmuller T, Abbet C, Bozorgtabar B, Clarke H, Petignat P, Vassilakos P, et al.
Comput Biol Med
. 2023 Dec;
169:107809.
PMID: 38113684
Screening Papanicolaou test samples has proven to be highly effective in reducing cervical cancer-related mortality. However, the lack of trained cytopathologists hinders its widespread implementation in low-resource settings. Deep learning-assisted...
7.
Petignat P, Vassilakos P, Clarke H, Kenfack B
Prev Med
. 2023 Jul;
174:107621.
PMID: 37453697
No abstract available.
8.
Vassilakos P, Clarke H, Murtas M, Stegmuller T, Wisniak A, Akhoundova F, et al.
J Am Soc Cytopathol
. 2023 Mar;
12(3):170-180.
PMID: 36922319
Introduction: Cytology is an option for triaging human papillomavirus (HPV)-positive women. The interpretation of cytologic slides requires expertise and financial resources that are not always available in resource-limited settings. A...
9.
Vinals R, Jonnalagedda M, Petignat P, Thiran J, Vassilakos P
Diagnostics (Basel)
. 2023 Mar;
13(5).
PMID: 36899979
Visual inspection with acetic acid (VIA) is one of the methods recommended by the World Health Organization for cervical cancer screening. VIA is simple and low-cost; it, however, presents high...
10.
Balli C, Kenfack B, Horo A, Jeronimo J, Abatsong E, Wisniak A, et al.
JCO Glob Oncol
. 2023 Feb;
9:e2200241.
PMID: 36854076
Purpose: Thermal ablation (TA) has become the conventional method for treatment of precancerous cervical lesions in low-resource settings. After TA, both the squamocolumnar junction (SCJ) and the transformation zone (TZ)...